NCT02064569View on ClinicalTrials.gov

Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

February 13, 2014

Primary Completion Date

June 25, 2020

Study Completion Date

June 25, 2020

Conditions

Leber Hereditary Optic Neuropathy

Interventions

GENETIC

GS010

Trial Locations (1)

75012

CIC du CHNO DES QUINZE-VINGTS, Paris

Sponsors

Lead Sponsor

GenSight Biologics

All Listed Sponsors

lead

GenSight Biologics

INDUSTRY